ArticleThe Gerontologist2026
Evaluating the Hebrew version of the financial exploitation vulnerability scale.
Article in The Gerontologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BACKGROUND AND
objectivesAssessing financial exploitation (FE) in older adults has proved challenging for various reasons, including low base rates, underreporting, and/or inaccurate reporting. Measuring FE risk is one way to overcome some of these inherent challenges, yet few measures exist that do so. One measure that holds great promise is the Financial Exploitation Vulnerability Scale, and its short-form (FEVS, FEVS-SF, respectively). The present study examined the measurement property evidence for a Hebrew version of the FEVS and FEVS-SF. RESEARCH DESIGN AND
methodsParticipants (N = 1281; M age = 69.98; SD = 7.39) from four separate studies were included in an amalgamated sample. Participants completed basic demographic measures, the FEVS in Hebrew (from which the FEVS-SF was derived), and a questionnaire on self-reported history of FE. Factor structure (structural validity), internal consistency estimates, and discriminative (known groups) construct validity of the FEVS and FEVS-SF were examined.
resultsA clear factor structure was not found for the FEVS, but a two-factor solution yielded a good model fit for the FEVS-SF, with two conceptually meaningful factors identified (financial well-being and financial decision making). Reliability estimates were acceptable for both the FEVS (0.77) and FEVS-SF (0.81). Discriminative validity was also supported; participants with a self-reported history of FE scored significantly higher on both measure versions compared to participants denying a history of FE. DISCUSSION AND IMPLICATIONS: Findings support the use of the FEVS-SF in Hebrew to measure FE vulnerability. The measure can be administered easily and at low cost, and may serve useful to researchers and clinicians alike.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.